CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 214 filers reported holding CYTOKINETICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,328,244 | -27.6% | 112,975 | +12.6% | 0.05% | -29.2% |
| Q4 2022 | $4,598,220 | -20.9% | 100,354 | -16.4% | 0.07% | -10.0% |
| Q3 2022 | $5,816,000 | +64.5% | 120,000 | +33.3% | 0.08% | +63.3% |
| Q2 2022 | $3,536,000 | +60.1% | 90,000 | +50.0% | 0.05% | +88.5% |
| Q1 2022 | $2,208,000 | -19.2% | 60,000 | 0.0% | 0.03% | -13.3% |
| Q4 2021 | $2,734,000 | -47.2% | 60,000 | -58.6% | 0.03% | -49.2% |
| Q3 2021 | $5,182,000 | +468.8% | 145,000 | +215.2% | 0.06% | +391.7% |
| Q2 2021 | $911,000 | +35.0% | 46,000 | +41.5% | 0.01% | -20.0% |
| Q4 2020 | $675,000 | -96.2% | 32,500 | -96.0% | 0.02% | -96.4% |
| Q3 2020 | $17,568,000 | +1040.8% | 811,500 | +1142.7% | 0.41% | +705.9% |
| Q2 2020 | $1,540,000 | +213.0% | 65,300 | +56.5% | 0.05% | +82.1% |
| Q1 2020 | $492,000 | +200.0% | 41,736 | +189.8% | 0.03% | +211.1% |
| Q3 2019 | $164,000 | -51.3% | 14,400 | -52.0% | 0.01% | -47.1% |
| Q2 2019 | $337,000 | – | 30,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |